These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1547423)

  • 1. Acceptability of opportunistic screening for occult gastrointestinal blood loss.
    Hobbs FD; Cherry RC; Fielding JW; Pike L; Holder R
    BMJ; 1992 Feb; 304(6825):483-6. PubMed ID: 1547423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient compliance with colorectal cancer screening in general practice.
    Mant D; Fuller A; Northover J; Astrop P; Chivers A; Crockett A; Clements S; Lawrence M
    Br J Gen Pract; 1992 Jan; 42(354):18-20. PubMed ID: 1586526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Faecal occult blood screening for colorectal neoplasia: a randomized trial of three days or six days of tests.
    Thomas WM; Pye G; Hardcastle JD; Mangham CM
    Br J Surg; 1990 Mar; 77(3):277-9. PubMed ID: 2322789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for colorectal cancer: reasons for refusal of faecal occult blood testing in a general practice in England.
    Hynam KA; Hart AR; Gay SP; Inglis A; Wicks AC; Mayberry JF
    J Epidemiol Community Health; 1995 Feb; 49(1):84-6. PubMed ID: 7707012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An industry based approach to colorectal cancer screening in an asymptomatic population.
    Hart AR; Glover N; Howick-Baker J; Mayberry JF
    Postgrad Med J; 2003 Nov; 79(937):646-9. PubMed ID: 14654576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case-control study to evaluate efficacy of screening for faecal occult blood.
    Lazovich D; Weiss NS; Stevens NG; White E; McKnight B; Wagner EH
    J Med Screen; 1995; 2(2):84-9. PubMed ID: 7497161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer prevention. An approach to increasing compliance in a faecal occult blood test screening programme.
    Hart AR; Eaden J; Barnett S; de Bono AM; Mayberry JF
    J Epidemiol Community Health; 1998 Dec; 52(12):818-20. PubMed ID: 10396524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Faecal occult blood screening: knowledge, attitudes, and practice in four Hong Kong primary care clinics.
    Tam TK; Ng KK; Lau CM; Lai TC; Lai WY; Tsang LC
    Hong Kong Med J; 2011 Oct; 17(5):350-7. PubMed ID: 21979470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is an opportunistic primary care-based intervention for non-responders to bowel screening feasible and acceptable? A mixed-methods feasibility study in Scotland.
    Calanzani N; Cavers D; Vojt G; Orbell S; Steele RJC; Brownlee L; Smith S; Patnick J; Weller D; Campbell C
    BMJ Open; 2017 Oct; 7(10):e016307. PubMed ID: 29025829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect on compliance of a health education leaflet in colorectal cancer screening in general practice in central England.
    Hart AR; Barone TL; Gay SP; Inglis A; Griffin L; Tallon CA; Mayberry JF
    J Epidemiol Community Health; 1997 Apr; 51(2):187-91. PubMed ID: 9196650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for colorectal cancer: a general-practice-based study.
    Marjoram J; Strachan R; Allan A; Allan E
    Br J Gen Pract; 1996 May; 46(406):283-86. PubMed ID: 8762743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-administered faecal occult blood tests do not increase compliance with screening for colorectal cancer: results of a randomized controlled trial.
    Verne J; Kettner J; Mant D; Farmer A; Mortenson N; Northover J
    Eur J Cancer Prev; 1993 Jul; 2(4):301-5. PubMed ID: 8358281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer.
    Hardcastle JD; Chamberlain JO; Robinson MH; Moss SM; Amar SS; Balfour TW; James PD; Mangham CM
    Lancet; 1996 Nov; 348(9040):1472-7. PubMed ID: 8942775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for colorectal cancer using the faecal occult blood test, hemoccult.
    Towler BP; Irwig L; Glasziou P; Weller D; Kewenter J
    Cochrane Database Syst Rev; 2000; (2):CD001216. PubMed ID: 10796760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting compliance in colorectal cancer screening. Results of a study performed in Ballarat.
    Macrae FA; St John DJ; Ambikapathy A; Sharpe K; Garner JF
    Med J Aust; 1986 Jun; 144(12):621-3. PubMed ID: 3713601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of self-administered faecal occult blood tests on compliance with screening for colorectal cancer: results of a survey of those invited.
    Hunter W; Farmer A; Mant D; Verne J; Northover J; Fitzpatrick R
    Fam Pract; 1991 Dec; 8(4):367-72. PubMed ID: 1800202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of colorectal cancer screening in Finland: experiences from the first three years of a public health programme.
    Malila N; Oivanen T; Hakama M
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S25-8. PubMed ID: 18368636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limitations of the faecal occult blood test in screening for colorectal cancer.
    Delcò F; Sonnenberg A
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does use of the Coloscreen Self-Test improve patient compliance with fecal occult blood screening?
    Park SI; Saxe JC; Weesner RE
    Am J Gastroenterol; 1993 Sep; 88(9):1391-4. PubMed ID: 8362837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of mailing fecal occult blood test kits on return rate in a community cancer screening center.
    Mahon SM
    Oncol Nurs Forum; 1995 Sep; 22(8):1259-63. PubMed ID: 8532551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.